Here’s what you need to know:
1. Proove Biosciences uses technology to personalize pain management options for those undergoing temporomandibular joint dysfunction treatment.
2. The company’s tests evaluate pain perception and assess opioid use disorder risk prior to the dental operation.
3. Proove Biosciences’ ultimate goal is to decrease the amount that dentists prescribe opioid analgesics.
This month, Proove Biosciences is slated to launch a new test that evaluates contributing causes to temporomandibular joint dysfunction pain.
More articles on dental news:
American Association of Dental Office Management awards sustainability award to Claudia Paye: 3 things to know
American Dental Partners to implement patient feedback platform PatientTrak: 3 notes
Academy of Osseointegration opens applications for research grants up to $30k: 3 notes
